Patent details

EP2817286 Title: KINASE INHIBITORS FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP2817286
PCT Application Number:
AU2013000290
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137646139
PCT Publication Number:
WO2013138863
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
KINASE INHIBITORS FOR THE TREATMENT OF CANCER
French Title of Invention:
INHIBITEURS DE KINASE DESTINÉS AU TRAITEMENT DU CANCER
German Title of Invention:
KINASEHEMMER ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
22/03/2013
Grant date:
06/06/2018
EP Publication Date:
31/12/2014
PCT Publication Date:
26/09/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/06/2018
EP B1 Publication Date:
06/06/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/03/2019
Expiration date:
22/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/05/2018
 
 

Name:
Pitney Pharmaceuticals Pty Limited
Address:
Suite 39, 1 Freshwater Parade, Claremont, Western Australia 6010, Australia (AU)

Inventor

Name:
MORRIS, David Lawson
Address:
Australia (AU)

Priority

Priority Number:
2012901199
Priority Date:
23/03/2012
Priority Country:
Australia (AU)

Classification

IPC classification:
A61K 31/277; A61P 35/00; C07C 255/29; C07C 317/14; C07C 317/44; C07C 323/62;

Publication

European Patent Bulletin

Issue number:
201823
Publication date:
06/06/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages